Transfusion-Transmitted Cytomegalovirus Prevention in Neonates

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1983
To evaluate the capacity of intravenously administered cytomegalovirus (CMV)-immune globin (CMVIG) to immunize high risk premature infants against CMV infections.
Epistemonikos ID: 70d543fcd056e51fff9d860bb5783abc2b8d355d
First added on: May 03, 2024